ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $731,391 | -73.1% | 35,695 | -73.9% | 0.00% | -100.0% |
| Q2 2023 | $2,719,031 | +546.5% | 136,841 | +457.4% | 0.00% | – |
| Q1 2023 | $420,576 | +30.6% | 24,552 | +49.2% | 0.00% | – |
| Q4 2022 | $321,985 | +77.9% | 16,453 | +45.0% | 0.00% | – |
| Q3 2022 | $181,000 | +1.1% | 11,346 | -12.7% | 0.00% | – |
| Q2 2022 | $179,000 | -25.1% | 12,996 | +19.0% | 0.00% | – |
| Q4 2021 | $239,000 | -78.5% | 10,925 | -70.6% | 0.00% | – |
| Q3 2021 | $1,111,000 | -42.0% | 37,165 | -14.1% | 0.00% | -100.0% |
| Q2 2021 | $1,917,000 | +61.1% | 43,288 | +61.4% | 0.00% | – |
| Q1 2021 | $1,190,000 | -36.1% | 26,817 | -21.0% | 0.00% | -100.0% |
| Q4 2020 | $1,861,000 | +309.9% | 33,935 | +70.9% | 0.00% | – |
| Q3 2020 | $454,000 | – | 19,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |